Cognizant hits back, says Infosys deflecting attention

BENGALURU: After Cognizant's healthcare subsidiary TriZetto initiated legal proceedings against Infosys regarding the misappropriation of trade secrets, along with audit non-compliance, Cognizant's latest court submission alleged that Infosys attempted to deflect focus from core issues.

"Infosys was caught red-handed misappropriating TriZetto trade secrets that Infosys originally accessed through Non-Disclosure and Access Agreements (NDAAs). When confronted, Infosys obfuscated to the maximum extent possible, asking TriZetto to simply trust, based on nothing, that there had been no wrongdoing. When TriZetto refused to take Infosys at its word and demanded an audit of Infosys's use of TriZetto's information, as explicitly permitted under the NDAAs for any reason (much less rampant trade secret misappropriation), Infosys refused to comply," the US court filing showed.

TriZetto has petitioned the court to reject Infosys's motion and direct Infosys to submit all documents that it currently withholds.

Cognizant acquired the healthcare tech firm TriZetto for $2.7 billion in 2014. Among its suite of software products are acets and QNXT, which are sophisticated software products that have simplified the processing of health insurance claims for millions of Americans. Both Facets and QNXT are built upon TriZetto's confidential and trade secret information. Cognizant alleged that Infosys misappropriated TriZetto's trade secrets to create a repository of test cases for Facets, which Infosys markets as its own and utilises to unfairly compete with TriZetto.

An email sent to Infosys and Cognizant regarding the development did not elicit a response by the time of going to the press.

Stay informed with the latest business news, updates on bank holidays and public holidays.

Unlock Investment Potential: Enroll in ET's Stock Valuation Workshop - Batch 3. Secure Your Spot Now!